Dementia linked to diabetes, herpes as research looks beyond brain proteins to find cause
Protein clumps in the brain have long been associated with Alzheimer’s, but other potential causes of the condition are now ...
At-home smell test could detect Alzheimer’s disease years before symptoms start
Researchers at Mass General Brigham may have developed an easy and inexpensive way to detect early signs of dementia.
Newcastle author of 'next Vera' raises thousands for Alzheimer's Research with 75-mile walk
Trevor Wood walked from Forum Books in Corbridge to Drake the Bookshop in Stockton-on-Tees stopping at four more bookshops on ...
Dementia may not always be the threat it is now. Here’s why
Obesity and diabetes, more common in recent decades, could lead to more dementia, but much touted new drugs that reduce them ...
Verywell Health on MSN10d
7 Medications for Dementia and Alzheimer's Disease
Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.
Alzheimer’s disease study: Boston researchers create at-home smell test for early detection
Albers and colleagues are interested in whether olfactory dysfunction — the sometimes-subtle loss of sense of smell — can ...
Breakthrough Drug Cuts Alzheimer’s Risk by 50% in High-Risk Patients
A clinical trial involving individuals genetically predisposed to develop early-onset Alzheimer’s disease suggests that ...
Rolling Out4d
New study reveals hidden genetic risks for Alzheimer’s
New research identifies 16 genes linked to Alzheimer's risk while experts emphasize powerful lifestyle changes that could ...
Alzheimer’s-related dementia could be prevented by experimental drug, researchers say
For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...
Montgomery quilters impact dementia patients via “fidget quilts”
They’re called “fidget quilts,” and they’re not made for keeping warm. Instead, they’re designed to provide much needed ...
Alzheimer’s Center
The rates of dementia and Alzheimer’s disease are expected to double between 2030 and 2060 due in part to an estimated 50% of patients not being diagnosed ...
Medscape2d
Alzheimer Drug Donanemab Gets No-Go From European Regulator
The EMA has recommended refusing marketing authorization for donanemab, a monoclonal antibody against amyloid beta, in the ...